146 related articles for article (PubMed ID: 36357601)
1. Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer.
David R; Hiwase M; Kahokehr AA; Lee J; Watson DI; Leung J; O'Callaghan ME
World J Urol; 2022 Dec; 40(12):2911-2918. PubMed ID: 36357601
[TBL] [Abstract][Full Text] [Related]
2. Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate?
Luo HL; Fang FM; Kang CH; Chuang YC; Chiang PH
Int Urol Nephrol; 2013 Feb; 45(1):113-9. PubMed ID: 22972569
[TBL] [Abstract][Full Text] [Related]
3. Incidence of genitourinary complications following radiation therapy for localised prostate cancer.
David RV; Kahokehr AA; Lee J; Watson DI; Leung J; O'Callaghan ME
World J Urol; 2022 Oct; 40(10):2411-2422. PubMed ID: 35951087
[TBL] [Abstract][Full Text] [Related]
4. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
[TBL] [Abstract][Full Text] [Related]
5. Genitourinary toxicity in patients receiving TURP prior to hypofractionated radiotherapy for clinically localized prostate cancer: A scoping review.
Neerhut T; Grills R; Lynch R; Preece PD; McLeod K
Urol Oncol; 2024 Jun; 42(6):165-174. PubMed ID: 38503591
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity.
Devisetty K; Zorn KC; Katz MH; Jani AB; Liauw SL
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1060-5. PubMed ID: 20045267
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
No D; Osterberg EC; Otto B; Naftali I; Choi B
Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
[TBL] [Abstract][Full Text] [Related]
8. High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.
Chao M; Bolton D; Lim Joon D; Chan Y; Lawrentschuk N; Ho H; Spencer S; Wasiak J; Guerrieri M; Ow D; Troy A; Pham T; Sengupta S; Tan A; McMillan K; Koufogiannis G; Foroudi F; Ng M; Khoo V
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):415-421. PubMed ID: 30908894
[TBL] [Abstract][Full Text] [Related]
9. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
Ishiyama H; Hirayama T; Jhaveri P; Satoh T; Paulino AC; Xu B; Butler EB; Teh BS
Am J Clin Oncol; 2014 Jun; 37(3):297-304. PubMed ID: 22706173
[TBL] [Abstract][Full Text] [Related]
10. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
Jarosek SL; Virnig BA; Chu H; Elliott SP
Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
12. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
13. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
[TBL] [Abstract][Full Text] [Related]
14. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
[TBL] [Abstract][Full Text] [Related]
15. Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning.
Hathout L; Folkert MR; Kollmeier MA; Yamada Y; Cohen GN; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):312-9. PubMed ID: 25304791
[TBL] [Abstract][Full Text] [Related]
16. Impact of High-Dose-Rate and Low-Dose-Rate Brachytherapy Boost on Toxicity, Functional and Cancer Outcomes in Patients Receiving External Beam Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Parry MG; Nossiter J; Sujenthiran A; Cowling TE; Patel RN; Morris M; Berry B; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1219-1229. PubMed ID: 33279595
[TBL] [Abstract][Full Text] [Related]
17. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
Sarosdy MF
Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
[TBL] [Abstract][Full Text] [Related]
18. Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
Pasalic D; Barocas DA; Huang LC; Zhao Z; Koyama T; Tang C; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup AM; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Hoffman KE
Cancer; 2021 Jun; 127(11):1912-1925. PubMed ID: 33595853
[TBL] [Abstract][Full Text] [Related]
19. Patients with renal transplant and moderate-to-severe LUTS benefit from urodynamic evaluation and early transurethral resection of the prostate.
Righetto M; Mancini M; Modonutti D; Calpista A; Beltrami P; Dal Moro F
World J Urol; 2021 Dec; 39(12):4397-4404. PubMed ID: 34480590
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
